Arbutus Biopharma (ABUS) Earnings Date, Estimates & Call Transcripts → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ABUS Stock Alerts $2.75 +0.11 (+4.17%) (As of 05:11 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 2Before Market OpensConfirmedActual EPS (Feb. 29) -$0.12 Consensus EPS (Feb. 29) -$0.12 Read Call TranscriptListen to Call Get Arbutus Biopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for ABUS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueABUS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABUS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Arbutus Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.17)($0.17)($0.17)Q2 20241($0.17)($0.17)($0.17)Q3 20241($0.18)($0.18)($0.18)Q4 20241($0.18)($0.18)($0.18)FY 20244($0.70)($0.70)($0.70)ABUS Earnings Date and InformationArbutus Biopharma last posted its quarterly earnings results on February 29th, 2024. The biopharmaceutical company reported ($0.12) EPS for the quarter, hitting the consensus estimate of ($0.12). The company earned $2.15 million during the quarter, compared to analysts' expectations of $4.74 million. Arbutus Biopharma has generated ($0.44) earnings per share over the last year (($0.44) diluted earnings per share). Earnings for Arbutus Biopharma are expected to decrease in the coming year, from ($0.39) to ($0.43) per share. Arbutus Biopharma has confirmed that its next quarterly earnings report will be published on Thursday, May 2nd, 2024. Arbutus Biopharma will be holding an earnings conference call on Thursday, May 2nd at 8:45 AM Eastern. Interested parties can register for or listen to the call.. Read More Arbutus Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/2/2024Confirmed)------- 2/29/2024Q4 2023($0.12)($0.12)-($0.12)$4.74 million$2.15 million 11/7/2023Q3 2023($0.12)($0.12)-($0.12)$3.78 million$4.66 million8/3/2023Q2 2023($0.12)($0.10)+$0.02($0.10)$5.02 million$4.65 million5/4/2023Q1 2023($0.14)($0.10)+$0.04($0.10)$4.52 million$6.69 million3/2/2023Q4 2022($0.14)($0.14)-($0.14)$6.31 million$6.25 million11/9/2022Q3 2022($0.12)($0.12)-($0.12)$11.12 million$5.95 million Get the Latest News and Ratings for ABUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.13)($0.10)+$0.03($0.10)$5.37 million$14.24 million 5/5/2022Q1 2022($0.13)($0.11)+$0.02($0.11)$5.77 million$12.58 million 3/3/2022Q4 2021($0.16)($0.15)+$0.01($0.15)$3.39 million$3.21 million 11/4/2021Q3 2021($0.24)($0.24)-($0.24)$2.36 million$3.34 million 8/4/2021Q2 2021($0.21)($0.23)($0.02)($0.23)$2.07 million$2.33 million 5/4/2021Q1 2021($0.23)($0.21)+$0.02($0.21)$3.87 million$2.11 million Arbutus Biopharma Earnings - Frequently Asked Questions When is Arbutus Biopharma's earnings date? Arbutus Biopharma has confirmed that its next quarterly earnings data will be published on Thursday, May 2nd, 2024. Learn more on ABUS's earnings history. Did Arbutus Biopharma beat their earnings estimates last quarter? In the previous quarter, Arbutus Biopharma (NASDAQ:ABUS) reported ($0.12) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.12). Learn more on analysts' earnings estimate vs. ABUS's actual earnings. How can I listen to Arbutus Biopharma's earnings conference call? The conference call for Arbutus Biopharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Arbutus Biopharma's conference call transcript? The conference call transcript for Arbutus Biopharma's latest earnings report can be read online. Read Transcript How much revenue does Arbutus Biopharma generate each year? Arbutus Biopharma (NASDAQ:ABUS) has a recorded annual revenue of $18.14 million. How much profit does Arbutus Biopharma generate each year? Arbutus Biopharma (NASDAQ:ABUS) has a recorded net income of -$72.85 million. ABUS has generated -$0.44 earnings per share over the last four quarters. What is Arbutus Biopharma's EPS forecast for next year? Arbutus Biopharma's earnings are expected to decrease from ($0.39) per share to ($0.43) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CALT Earnings Results PAHC Earnings Results ALT Earnings Results IGMS Earnings Results SLRN Earnings Results CMPS Earnings Results APLT Earnings Results KALV Earnings Results OCS Earnings Results ANAB Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:ABUS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersGreat Crypto BullWeiss RatingsThe Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arbutus Biopharma Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
